September 24 & 25th
All Virtual!
The CMT Research Foundation is laser-focused on delivering treatments and cures for Charcot-Marie-Tooth disease during our lifetime.
The 2021 Global CMT Research Convention will unite researchers, pharma companies, government and patients to discuss and try to find solutions for the most pressing problems in CMT research.
Come learn what the future holds for CMT and how you can help end this disease!
September 24 & 25
September 24
For the Research Community
For researchers, industry and government agencies to:
- SHARE the latest in CMT drug development research
- UNITE their voices and streamline their work
- SOLVE the most pressing issues facing CMT drug development
September 25
For Patients
A day for the patient community to:
- LEARN about recent developments and clinical trials in CMT
- INTERACT with key research experts
- ACT to advance treatments for CMT
The Scientific Programming Committee
Marina Kennerson, PhD – Chair
Professor of Neurogenetics and Neuroscience
ANZAC Research Institute and University of Sydney, Australia
Carla Taveggia, PhD – Vice Chair
Director, Division of Neuroscience
Ospedale San Raffaele, Milan, Italy
Charles Abrams, MD, PhD
Professor of Neurology and Rehabilitation
University of Illinois, Chicago (UIC)
Vice President of Biology
Agios Pharmaceuticals
Robert Burgess, PhD
Professor, The Rare and Orphan Disease Center
The Jackson Laboratory
Amanda Haidet-Phillips, PhD
Senior Director, Translational Medicine
Novartis Gene Therapies
Program Director, Neurogenetics, Division of Neuroscience
U.S. National Institute of Neurological Disorders and Stroke (NINDS)
Jonathan Sabbagh, PhD
Scientific Portfolio Director
Muscular Dystrophy Association
Tiina Urv, PhD
Program Director, Office of Rare Diseases Research
U.S. National Center for Advancing Translational Sciences (NCATS)
Thank you to our sponsors!
Address
4062 Peachtree Road
Suite A209
Atlanta, GA 30319
Phone Number
404.806.7180
